Literature DB >> 16501898

Distribution of four capsular serotypes of Enterococcus faecalis among clinical isolates from different geographical origins and infection sites.

M Hufnagel1, V J Carey, L Baldassarri, R R Reinert, J Huebner.   

Abstract

BACKGROUND: Enterococci possess capsular polysaccharide antigens that are the targets of opsonic antibodies. These antibodies are potential candidates for development as immunotherapy.
MATERIAL AND METHODS: The present study analyzes the distribution of four capsular serotypes within a collection of 157 isolates of Enterococcus faecalis from four countries with different sites of clinical infection.
RESULTS: By using a capsular polysaccharide-specific ELISA, 42% of the isolates were grouped into one of four serogroups, and another 9% showed cross-reactivity between two serotype-specific sera. Heterogeneity of serotype distribution by both geographical origin and infection site was observed.
CONCLUSION: Half of the strain collection could be typed with four serotype-specific sera. No serotype from a given country or infection site clearly predominated.

Entities:  

Mesh:

Year:  2006        PMID: 16501898     DOI: 10.1007/s15010-006-4100-5

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  5 in total

1.  Capsular polysaccharide production in Enterococcus faecalis and contribution of CpsF to capsule serospecificity.

Authors:  Lance R Thurlow; Vinai Chittezham Thomas; Lynn E Hancock
Journal:  J Bacteriol       Date:  2009-08-14       Impact factor: 3.490

2.  Importance of the epa locus of Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract infection.

Authors:  Kavindra V Singh; Roshan J Lewis; Barbara E Murray
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

3.  A novel role for D-alanylation of lipoteichoic acid of enterococcus faecalis in urinary tract infection.

Authors:  Dominique Wobser; Liaqat Ali; Elisabeth Grohmann; Johannes Huebner; Türkan Sakinc
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

Review 4.  Potential targets for next generation antimicrobial glycoconjugate vaccines.

Authors:  Francesca Micoli; Paolo Costantino; Roberto Adamo
Journal:  FEMS Microbiol Rev       Date:  2018-05-01       Impact factor: 16.408

Review 5.  Advances and Prospects in Vaccine Development against Enterococci.

Authors:  Ermioni Kalfopoulou; Johannes Huebner
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.